Precautions - smith&nephew RENASYS GO 66801244 Manual De Instrucciones

EN
9. When operating, transporting or disposing of
device and accessories, there is risk of infectious
liquids being aspirated or contamination of
device assembly through incorrect use. Universal
precautions should be observed whenever working
with potentially contaminated components or
equipment.
10. Device and canister kits are provided non-sterile
and should not be placed within a sterile field.

Precautions

1. More frequent device and wound dressing
monitoring, should be taken for patients who are
or may be:
• Suffering from infected blood vessels
• Receiving anticoagulant therapy or platelet
aggregation inhibitors, in addition to patients
with intrinsic coagulation problems such as low
platelet counts
• Actively bleeding or have friable blood vessels
or organs
• Suffering from difficult wound hemostasis
• Untreated for malnutrition
• Noncompliant or combative
• Suffering from wounds in close proximity to
blood vessels or delicate fascia
When monitoring patients for delivery of therapy,
ensure wound dressing is free of air leaks, fully
compressed and firm to the touch.
2. As a condition of use, device should only be used
by qualified and authorized personnel. User must
have necessary knowledge of the specific medical
application for which NPWT is being used.
3. For patients with high risk of bleeding, use 300ml
canister. Ensure the 300ml canister viewing is
checked frequently for signs of bleeding.
4. In the event of heavy or viscous drainage, drainage
with sediment or when blood is present, regular
monitoring and more frequent dressing changes
may be required to reduce the risk of interruption
of therapy, maceration, infection, and ensure
proper exudate removal.
5. Underlying structures, such as bone, tendons,
ligaments and nerves should be covered with
natural tissue or a non-adherent dressing layer
prior to applying the NPWT dressing to ensure
protection and minimize the risk of damage from
direct contact with the dressing.
6. To minimize the risk of bradycardia, do not place
NPWT in proximity to the vagus nerve.
7. In the event a patient with spinal cord injury
experiences autonomic dysreflexia, discontinue
use of NPWT and immediately seek medical
assistance.
8. When treating enteric fistulas, do not place NPWT
dressing in direct contact with exposed bowel.
Cover the wound bed, including fistula opening,
with non-adherent gauze or with one layer of saline
moistened gauze. During the course of treatment
patient's fluid levels must be closely monitored.
9. Avoid use of circumferential dressings except in
cases of oedema or heavily exuding extremities,
where this technique may be necessary to
maintain a seal. Consider using multiple drapes
to minimize risk of decreased distal circulation.
Regularly assess distal pulses, and discontinue
therapy if changes in circulation are detected.
10. Monitor patient for any signs of local or systemic
infection. Infected wounds may require more
frequent dressing changes. As NPWT is not
intended to directly treat infection, if there are any
signs of systemic infection or advancing infection at
wound area, contact treating clinician immediately.
11. If multiple pieces of foam or gauze are needed
to fill the wound profile, count and record how
many pieces are present to ensure all pieces are
removed at a dressing change to minimize the risk
of retention and possible infection.
12. NPWT should remain on for duration of treatment.
The length of time a patient may be disconnected
from device is a clinical decision based on individual
characteristics of patient and wound. Factors to
consider include location of wound, volume of
drainage, integrity of dressing seal, assessment of
bacterial burden and patient's risk of infection.
13. Do not use a dressing kit with breached or
damaged packaging.
14. Use of NPWT presents a risk of tissue in-growth.
Tissue in-growth may be reduced by reducing
therapy pressure, using a wound contact layer or
increasing the frequency of dressing changes.
15. NPWT should not be painful. If patient reports
discomfort, consider reducing pressure setting and
use of a wound contact layer. Pressure setting is a
clinical decision based on individual characteristics
of patient and wound. Factors to consider include
location of wound, volume of drainage and integrity
of dressing seal.
16. Maintain regular monitoring of device and wound
site during therapy to ensure therapeutic treatment
and patient comfort.
8